Brief: Mymd Pharmaceuticals Announces Publication Of Phase 1 Data For Oral Tnf-Alpha Inhibitor Mymd-1 In Peer-Reviewed Journal Drug Research

Q/C Technologies

14/11/2022 18:07

Nov 14 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS ANNOUNCES PUBLICATION OF PHASE 1 DATA
FOR
ORAL TNF-ALPHA INHIBITOR MYMD-1® IN PEER-REVIEWED JOURNAL DRUG
RESEARCH
    * MYMD PHARMACEUTICALS - MYMD-1 DEMONSTRATED FAVORABLE
SAFETY,
TOLERABILITY PROFILE ACROSS MULTIPLE DOSES, WITH NO CLINICALLY
RELEVANT ADVERSE EVENTS

Source text for Eikon:  ID:nBwQnCyma 
Further company coverage:  MYMD.O